Prevalence and bleeding risk associated with the concomitant use of direct oral anticoagulants and antiarrhythmic drugs in patients with atrial fibrillation, based on the French healthcare insurance database
ConclusionExposure to antiarrhythmic drugs was not associated with an increased risk of hospitalization for bleeding in patients with AF under rivaroxaban or apixaban.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Amiodarone | Atrial Fibrillation | Bleeding | Databases & Libraries | Diltiazem | Drugs & Pharmacology | France Health | Insurance | Study | Verapamil